Invitae Company

Invitae's mission is to bring genetics to mainstream medicine to improve healthcare for billions. Invitae’s medical-grade genetic testing analyzes genes to find changes that can potentially lead to disease. The range of testing specialization includes Pregnancy, Staying Healthy, Cancer, Genetic Illness. Their pre-pregnancy genetic testing and diagnostics services intends to set new standard of care for genetic screening of inherited disorders.


Connections from

Last Funding Type: Post-IPO Debt
Total Funding: 1989502111
Last Funding Date: 2021-04-05
Funding Status: IPO
Employee Number: 501-1000
Estimated Revenue: $100M to $500M
Investors Number: 16
Founded Date: 2010
Headquarters: San Francisco, California, United States
Industry: Women's Longevity
Acquisitions Number: 14